David A. Morrow

97.3k total citations · 22 hit papers
592 papers, 45.0k citations indexed

About

David A. Morrow is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David A. Morrow has authored 592 papers receiving a total of 45.0k indexed citations (citations by other indexed papers that have themselves been cited), including 393 papers in Cardiology and Cardiovascular Medicine, 156 papers in Surgery and 93 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David A. Morrow's work include Acute Myocardial Infarction Research (211 papers), Heart Failure Treatment and Management (102 papers) and Cardiac Imaging and Diagnostics (91 papers). David A. Morrow is often cited by papers focused on Acute Myocardial Infarction Research (211 papers), Heart Failure Treatment and Management (102 papers) and Cardiac Imaging and Diagnostics (91 papers). David A. Morrow collaborates with scholars based in United States, Canada and United Kingdom. David A. Morrow's co-authors include Eugene Braunwald, Christopher P. Cannon, Marc S. Sabatine, Sabina A. Murphy, Carolyn H. McCabe, James A. de Lemos, Eugene Braunwald, Harvey D. White, Allan S. Jaffe and Bernard Chaitman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

David A. Morrow

562 papers receiving 43.3k citations

Hit Papers

Fourth universa... 1986 2026 1999 2012 2018 2018 2018 2005 2000 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fourth universal definition of myocardial infarction (2018)
    2018 4.2k citations Kristian Thygesen, Joseph S. Alpert et al. European Heart Journal profile →
  2. Fourth Universal Definition of Myocardial Infarction (2018)
    2018 2.4k citations Kristian Thygesen, Joseph S. Alpert et al. Journal of the American College of Cardiology profile →
  3. Fourth Universal Definition of Myocardial Infarction (2018)
    2018 2.1k citations Kristian Thygesen, Joseph S. Alpert et al. Circulation profile →
  4. C-Reactive Protein Levels and Outcomes after Statin Therapy
    2005 1.7k citations Christopher P. Cannon, David A. Morrow et al. New England Journal of Medicine profile →
  5. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation
    2000 1.1k citations David A. Morrow, Elliott M. Antman et al. Circulation profile →
  6. Current therapy in theriogenology. 2.
    1986 1.1k citations David A. Morrow profile →
  7. The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
    2001 991 citations James A. de Lemos, David A. Morrow et al. New England Journal of Medicine profile →
  8. Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
    2010 842 citations James A. de Lemos, Torbjørn Omland et al. profile →
  9. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
    2018 776 citations David A. Morrow, Eugene Braunwald et al. New England Journal of Medicine profile →
  10. Acute Myocardial Infarction
    2017 746 citations Jeffrey L. Anderson, David A. Morrow New England Journal of Medicine profile →
  11. Vorapaxar in the Secondary Prevention of Atherothrombotic Events
    2012 656 citations David A. Morrow, Eugene Braunwald et al. New England Journal of Medicine profile →
  12. C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy
    1998 599 citations David A. Morrow, Elliott M. Antman et al. Journal of the American College of Cardiology profile →
  13. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes
    2002 557 citations Marc S. Sabatine, David A. Morrow et al. Circulation profile →
  14. Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
    2014 545 citations Benjamin M. Scirica, Eugene Braunwald et al. Circulation profile →
  15. Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes
    2005 539 citations Marc S. Sabatine, David A. Morrow et al. Circulation profile →
  16. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
    2015 299 citations Christian T. Ruff, Robert P. Giugliano et al. profile →
  17. Fourth Universal Definition of Myocardial Infarction (2018)
    2018 284 citations Kristian Thygesen, Joseph S. Alpert et al. profile →
  18. Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury
    2019 222 citations James A. de Lemos, L. Kristin Newby et al. Circulation profile →
  19. Cardiogenic Shock After Acute Myocardial Infarction
    2021 183 citations David A. Morrow et al. profile →
  20. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
    2023 81 citations David A. Morrow, Scott D. Solomon et al. Journal of the American College of Cardiology profile →
  21. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
    2025 31 citations Siddharth M. Patel, Robert P. Giugliano et al. New England Journal of Medicine profile →
  22. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock
    2025 20 citations Shashank S. Sinha, David A. Morrow et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Morrow United States 100 29.5k 12.8k 9.2k 5.0k 4.1k 592 45.0k
Allan S. Jaffe United States 99 38.7k 1.3× 13.6k 1.1× 13.9k 1.5× 3.9k 0.8× 4.1k 1.0× 622 51.4k
Jeffrey L. Anderson United States 91 20.7k 0.7× 8.4k 0.7× 4.6k 0.5× 5.5k 1.1× 2.9k 0.7× 527 36.8k
Hugo A. Katus Germany 106 38.5k 1.3× 11.9k 0.9× 9.1k 1.0× 4.5k 0.9× 16.2k 3.9× 1.4k 59.1k
James A. de Lemos United States 84 20.2k 0.7× 8.4k 0.7× 5.9k 0.6× 3.8k 0.8× 2.2k 0.5× 497 31.2k
Kent R. Bailey United States 107 33.2k 1.1× 8.6k 0.7× 9.3k 1.0× 5.8k 1.2× 2.6k 0.6× 584 44.1k
Maarten L. Simoons Netherlands 77 22.8k 0.8× 9.8k 0.8× 8.8k 1.0× 2.9k 0.6× 1.6k 0.4× 355 29.8k
Amir Lerman United States 107 27.2k 0.9× 15.0k 1.2× 11.0k 1.2× 3.4k 0.7× 8.0k 1.9× 881 51.0k
Thomas F. Lüscher Switzerland 127 28.1k 1.0× 13.6k 1.1× 6.0k 0.7× 4.4k 0.9× 11.6k 2.8× 1.1k 62.6k
Gerhard Schüler Germany 96 25.5k 0.9× 12.3k 1.0× 7.7k 0.8× 6.1k 1.2× 5.3k 1.3× 652 40.9k
Alan S. Go United States 93 25.3k 0.9× 5.6k 0.4× 3.0k 0.3× 6.5k 1.3× 2.9k 0.7× 483 47.4k

Countries citing papers authored by David A. Morrow

Since Specialization
Citations

This map shows the geographic impact of David A. Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Morrow more than expected).

Fields of papers citing papers by David A. Morrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Morrow. The network helps show where David A. Morrow may publish in the future.

Co-authorship network of co-authors of David A. Morrow

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Morrow. A scholar is included among the top collaborators of David A. Morrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Morrow. David A. Morrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wallentin, Lars, Johan Lindbäck, Ziad Hijazi, et al.. (2025). Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 85(11). 1173–1185. 1 indexed citations
2.
Kazi, Dhruv S., Rishi K. Wadhera, James A. de Lemos, et al.. (2025). Social Vulnerability and Long‐Term Cardiovascular Outcomes After COVID‐19 Hospitalization: An Analysis of the American Heart Association COVID‐19 Registry Linked With Medicare Claims Data. Journal of the American Heart Association. 14(7). e038073–e038073.
3.
Sinha, Shashank S., David A. Morrow, Navin K. Kapur, Rachna Kataria, & Robert O. Roswell. (2025). 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock. Journal of the American College of Cardiology. 85(16). 1618–1641. 20 indexed citations breakdown →
4.
O’Brien, Connor, Samuel B. Brusca, Christopher F. Barnett, et al.. (2024). Using Selection Criteria From the DanGer Shock Trial in a Contemporary Cohort With Cardiogenic Shock. Journal of the American College of Cardiology. 84(25). 2490–2493. 11 indexed citations
5.
Haller, Paul M., Petr Jarolı́m, Andrea Bellavia, et al.. (2024). Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 84(16). 1528–1540. 7 indexed citations
6.
Benz, Alexander P., Stefan H. Hohnloser, John W. Eikelboom, et al.. (2023). Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. European Heart Journal. 44(20). 1807–1814. 23 indexed citations
7.
Bhatt, Ankeet S., Lori B. Daniels, James A. de Lemos, et al.. (2023). Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry. American Heart Journal. 258. 149–156. 3 indexed citations
8.
Metkus, Thomas S., Carlos L. Alviar, Vivian M. Baird-Zars, et al.. (2023). Presentation and Outcomes of Patients With Preoperative Critical Illness Undergoing Cardiac Surgery. JACC Advances. 2(2). 100260–100260. 2 indexed citations
9.
Zelniker, Thomas A., David A. Morrow, Ofri Mosenzon, et al.. (2019). Abstract 15670: Relationship Between Baseline Cardiac Biomarkers and Cardiovascular Death or Hospitalization for Heart Failure in DECLARE-TIMI 58. Circulation. 2 indexed citations
10.
Thygesen, Kristian, Joseph S. Alpert, Allan S. Jaffe, et al.. (2018). Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 138(20). 2102 indexed citations breakdown →
11.
Anderson, Jeffrey L. & David A. Morrow. (2017). Acute Myocardial Infarction. New England Journal of Medicine. 376(21). 2053–2064. 746 indexed citations breakdown →
12.
Bonaca, Marc P., Mark A. Creager, Jeffrey W. Olin, et al.. (2016). Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar. JACC: Cardiovascular Interventions. 9(20). 2157–2164. 29 indexed citations
13.
Magnani, Giulia, Marc P. Bonaca, Eugene Braunwald, et al.. (2015). Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States. Journal of the American Heart Association. 4(3). e001505–e001505. 56 indexed citations
14.
Bonaca, Marc P., Benjamin M. Scirica, Mark A. Creager, et al.. (2013). Vorapaxar in Patients With Peripheral Artery Disease. Circulation. 127(14). 1522–1529. 210 indexed citations
15.
Morrow, David A., Eugene Braunwald, Marc P. Bonaca, et al.. (2012). Vorapaxar in the Secondary Prevention of Atherothrombotic Events. New England Journal of Medicine. 366(15). 1404–1413. 656 indexed citations breakdown →
16.
Sabatine, Marc S., David A. Morrow, James A. de Lemos, et al.. (2011). Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease. Circulation. 125(2). 233–240. 108 indexed citations
17.
Tang, W.H. Wilson, Gary S. Francis, David A. Morrow, et al.. (2007). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure. Clinical Biochemistry. 41(4-5). 210–221. 74 indexed citations
18.
Mega, Jessica L., David A. Morrow, Erika Östör, et al.. (2007). Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for ST-Elevation Myocardial Infarction. Circulation. 115(22). 2822–2828. 41 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allan S. Jaffe Breakdown of academic impact, for papers by Jeffrey L. Anderson Breakdown of academic impact, for papers by Hugo A. Katus Breakdown of academic impact, for papers by James A. de Lemos Breakdown of academic impact, for papers by Kent R. Bailey Breakdown of academic impact, for papers by Maarten L. Simoons Breakdown of academic impact, for papers by Amir Lerman Breakdown of academic impact, for papers by Thomas F. Lüscher Breakdown of academic impact, for papers by Gerhard Schüler Breakdown of academic impact, for papers by Alan S. Go
Rankless by CCL
2026